Diabetes and COVID-19
Diabetes and COVID-19
Buch
- Considerations and Clinical Management
- Herausgeber:
- Alyson K. Myers
- Verlag:
- Springer Nature Switzerland, 06/2024
- Einband:
- Kartoniert / Broschiert, Paperback
- Sprache:
- Englisch
- ISBN-13:
- 9783031285387
- Artikelnummer:
- 11895241
- Umfang:
- 240 Seiten
- Nummer der Auflage:
- 2023
- Auflage:
- 2023
- Gewicht:
- 414 g
- Maße:
- 235 x 155 mm
- Stärke:
- 13 mm
- Artikelnummer:
- 11895241
- Erscheinungstermin:
- 12.6.2024
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Weitere Ausgaben von Diabetes and COVID-19 |
Preis |
---|
Klappentext
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary / critical care, and general medicine.Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.

Diabetes and COVID-19
EUR 106,66*